// App-Quantinova.ai

BS8 : High sensitivity C-reactive protein at baseline predicts cardiovascular outcomes at 20-year follow-up in the ascot legacy study

Researchers

Presenter

  • Adam Hartley

Principal Investigators

  • Somayeh Rostamian

  • Amit Kaura

  • Paris Chrysostomou

  • Paul Welsh

  • Naveed Sattar

  • Peter Sever

  • Ramzi Khamis

Medical Centers

  • Imperial College London, Vascular Sciences, th floor ICTEM, Hamm London, LND W NN United Kingdom, UK

  • Glasgow University

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Hypertension

  • Diabetes

Biomarkers

  • Creatinine

  • High sensitivity C-reactive protein

Drug/Treatment

  • Atorvastatin

  • Amlodipine

  • Atenolol

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved